Mural Oncology plc (MURA) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 19 transactions totaling $143.5K, demonstrating a bearish sentiment with -$79.3K in net insider flow. The most recent transaction on Dec 5, 2025 involved a transaction of 99,290 shares valued at $0.
No significant insider buying has been recorded for MURA in the recent period.
No significant insider selling has been recorded for MURA in the recent period.
Based on recent SEC filings, insider sentiment for MURA is bearish with an Insider Alignment Score of 22/100 and a net flow of -$79.3K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Mural Oncology plc (MURA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading MURA stock, having executed 19 transactions in the past 90 days. The most active insider is Caroline Loew (Executive), who has made 6 transactions totaling $66.9K.
Get notified when executives and directors at MURA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | D. Cutler Adam | Executive | Disposition | 99,290 | $N/A | $0 | |
| Dec 5, 2025 | L. Goodman Vicki | Executive | Disposition | 84,727 | $N/A | $0 | |
| Dec 5, 2025 | Keson-brookes Maiken | Executive | Disposition | 68,834 | $N/A | $0 | |
| Dec 5, 2025 | Loew Caroline | Executive | Disposition | 293,059 | $N/A | $0 | |
| Nov 10, 2025 | L. Goodman Vicki | Executive | Sale | 5,036 | $2.08 | $10.5K | |
| Nov 3, 2025 | D. Cutler Adam | Executive | Sale | 7,148 | $2.09 | $14.9K | |
| Jul 22, 2025 | Keson-brookes Maiken | Executive | Sale | 2,572 | $2.48 | $6.4K | |
| Jul 18, 2025 | Keson-brookes Maiken | Executive | Sale | 2,158 | $2.48 | $5.4K | |
| Jul 7, 2025 | Loew Caroline | Executive | Sale | 12,531 | $2.43 | $30.5K | |
| Aug 14, 2024 | Altschuller Susan | Executive | Purchase | 10,000 | $3.21 | $32.1K | |
| Jul 18, 2024 | Keson-brookes Maiken | Executive | Sale | 2,157 | $3.41 | $7.4K | 10b5-1 |
| Jul 8, 2024 | Loew Caroline | Executive | Sale | 12,531 | $2.91 | $36.5K | 10b5-1 |
| Mar 1, 2024 | Keson-brookes Maiken | Executive | Award | 16,800 | $N/A | $0 | |
| Mar 1, 2024 | Loew Caroline | Executive | Award | 48,475 | $N/A | $0 | |
| Dec 14, 2023 | Keson-brookes Maiken | Executive | Award | 29,207 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 7 | $111.4K | 77.6% |
Purchase(P) | 1 | $32.1K | 22.4% |
Disposition(D) | 4 | $0 | 0.0% |
Award(A) | 7 | $0 | 0.0% |
Insider selling pressure at Mural Oncology plc has increased, with 5 insiders executing 19 transactions across all time. Total sales of $111.4K significantly outpace purchases of $32.1K, resulting in a net outflow of $79.3K. This selling activity appears largely discretionary, which may warrant closer attention from investors.